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ABSTRACT  
Self-assembling dipeptides conjugated to naphthalene show considerable promise as nanomaterial 
structures, biomaterials and drug delivery devices.  Biomaterial infections are responsible for high 
rates of patient mortality and morbidity.  The presence of biofilm bacteria, which thrive on implant 
surfaces, are a huge burden on healthcare budgets as they are highly resistant to current therapeutic 
strategies.  Ultrashort cationic self-assembled peptides represent a highly innovative and cost-
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effective strategy to form antibacterial nanomaterials.  Lysine conjugated variants display the 
greatest potency with 2% w/v NapFFKK hydrogels significantly reducing viable Staphylococcus 
epidermidis biofilm by 94%.  Reducing the size of the R-group methylene chain on cationic 
moieties resulted in reduction of antibiofilm activity.  The primary amine of the protruding R-
group tail may not be as readily available to interact with negatively charged bacterial membranes.  
Cryo-SEM, FTIR, CD spectroscopy and oscillatory rheology provided evidence of supramolecular 
hydrogel formation at physiological pH (pH 7.4).  Cytotoxicity assays against murine fibroblast 
(NCTC 929) cell lines confirmed the gels possessed reduced cytotoxicity relative to bacterial cells, 
with limited hemolysis upon exposure to equine erythrocytes.  The results presented in this paper 
highlight the significant potential of ultrashort cationic naphthalene peptides as future 
biomaterials. 
 
Introduction  
The increasing demand for biomaterials to replace normal physiological functions of the human 
body is largely attributed to an increase in life expectancy and advancement in modern healthcare 
and drug therapy.1  The biomaterial revolution has led to increased interest in the development of 
implants, biosensors, tissue scaffolds and wound dressings for medical applications. 2-5   
Hydrogels represent one of the most promising materials utilized in this field by mimicking the 
extracellular matrix of soft tissue, possessing key properties such as: biocompatibility; high water 
absorptivity and retention of three-dimensional architectures.6  However, one key limitation of 
unmodified hydrogels, for example poly (2-hydroxyethyl methacrylate) polymers, is their inability 
to resist infection by pathogenic microorganisms.7  The hydrogel surface provides an optimum 
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structure for microbial attachment and the production of a highly resistant biofilm phenotype that 
displays 10-1000 times the resistance to standard antimicrobial regimens, when compared to free-
floating planktonic forms.8  Medical device infections can be attributed to an increase in healthcare 
costs, patient morbidity, hospital stay and mortality.9 
Self-assembled peptide hydrogels and their nanostructures have attracted interest for use as 
biomaterials and drug delivery vehicles.10,11  Of greatest potential clinically are the ultrashort 
aromatic dipeptide variants that display similar gelation properties to larger β-sheets and turns; α-
helices and coiled coils; and peptide amphiphiles but at a reduced cost and ease of synthesis.12  
Ultrashort dipeptide gelators often consist of two phenylalanine building blocks conjugated to a 
molecule of high aromaticity, such as naphthalene (Nap) or 9-fluorenylmethoxycarbonyl 
(Fmoc).13,14  The presence of increased aromaticity confers improved structural integrity and 
superior gel strength to the molecule via π-π interactions.  Other intermolecular interactions, such 
as hydrogen bonding and van der Waal’s interactions, provided by the peptide backbone, are also 
vital to ensuring the structural integrity of such gels.  Diphenylalanine is the shortest structural 
recognition motif for the naturally occurring β-amyloid polypeptide, implicated in the formation 
of fibrous plaques in Alzheimer’s.  Researchers have harnessed the properties of aromatic groups 
for development of a range of diverse, short, nanomaterial structures in medical and technological 
research.15-17   
The peptide primary structure possesses several key properties making them an ideal biomaterial 
platform. These include: availability of moieties for functionalization; chemical versatility; 
biocompatibility; biodegradability and minimal immunogenicity.18  Peptides have also been shown 
to be antimicrobial, existing as defensive weapons against infection throughout nature.  
Antimicrobial activity is conferred by an optimal hydrophobic: charge balance that exists within 
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the peptide primary structure.19  Similarly the hydrophobic: hydrophilic balance governs gelation 
and self-assembly of peptides.20  Ultrashort variants exist displaying broad antimicrobial activity 
within a minimum peptide pharmacophore with hydrophobic bulk provided by lipophilic 
molecules such as fatty acids.21  The presence of cationic amino acids allows increased selectivity 
for negatively charged bacterial membranes rather than neutrally charged phospholipid bilayers.   
In this report we outline the synthesis and characterization of a group of ultrashort aromatic 
peptide molecules, which self-assemble into inherently antimicrobial hydrogel nanostructures at 
physiological pH and have the potential to be utilized as future antimicrobial biomaterials.  
 
Experimental Section 
Materials 
Fmoc and Boc protected amino acids and Wang resin (mesh size 100-200, 0.65 mmol/g) were 
obtained from Novabiochem, Merck KGaA (Darmstadt, Germany).  Cell viability reagent 
alamarBlue® was purchased from AbD Serotec (Oxford, UK).  37 % Hydrochloric acid (HCl), 
Acetonitrile (HPLC grade, ≥99.93%), 2-Naphthaleneacetic acid (>99% purity), Whatman® pH 
indicator paper (pH 0-14) and hydroxyl propyl methyl cellulose (HPMC) were obtained from 
Sigma-Aldrich (Dorset, UK ).  Sterile Nunc™ 96-well microtitre plates and sodium hydroxide 
(NaOH) ≥99.0% pellets were purchased from VWR International (Leicestershire, UK).  NCTC 
Clone 929 (ATCC CCL 1) murine fibroblast subcutaneous connective tissue cells, Staphylococcus 
epidermidis (ATCC 35984), Staphylococcus aureus (ATCC 29213), Pseudomonas aeruginosa 
(PAO1) and Escherichia coli (NCTC 11303) were sourced from LGC Standards (London, UK).  
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Fresh defibrinated equine erythrocytes were purchased from Laboratory Supplies & Instruments 
Ltd (Antrim, UK). 
 
Methods 
Peptide Synthesis and Characterization 
All peptides (Figure 1, NapFF, NapFFKK, NapFFFKK, NapFFOO, NapFFK’K’) were 
synthesized following standard Fmoc solid phase protocols on Wang resin, using a manual 
nitrogen bubbler apparatus.  Peptide elongation was effected using standard HBTU coupling 
chemistry in dimethylformamide (DMF) solvent with four-fold molar excess of diisopropyl 
ethylamine (DIEA) in DMF and a three-fold molar excess of each Fmoc-protected amino acid or 
naphthalene acetic acid.  Boc-Lysine(Fmoc)-OH was used to synthesize the epsilon (ε) variant 
NapFFK’K’.  All peptides were cleaved from the resin, to form carboxylic acid terminated 
peptides, using 95% trifluoroacetic acid (TFA), 2.5% triisopropylsilane and 2.5% thioanisole (3 
hours, room temperature), and precipitated using cold (-20 ºC) diethyl ether.  The identity of each 
peptide was confirmed by electrospray mass spectroscopy (Thermo Finnigan LCQ Deca ion trap) 
and 1H Nuclear Magnetic Resonance (1H NMR) analysis (Varian Unity Inova 400 spectrometer) 
in C2D6OS (d6-DMSO) (Figures S1-S5).  Peptide purity was analyzed by RP-HPLC using an 
Agilent 1260 Infinity system, fitted with a Gemini C18, 250 mm x 4.6 mm column, a 2-60% 
acetonitrile gradient [30min] in 0.05% TFA-water at a flow rate of 1.5 mL/min.  All peptides were 
found to have >95% purity. 
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Figure 1. Chemical structures of the naphthalene peptide derivatives investigated. 1) NapFF, 2) 
NapFFKK, 3) NapFFK’K’, 4) NapFFOO, 5) NapFFFKK 
 
Peptide Gelation 
Peptides were prepared and tested for gelation characteristics at concentrations of 2.0, 1.5, 1.0 
and 0.5% w/v as previously outlined.13  Peptides were initially suspended in 200 μL sterile 
deionized water.  All peptides possessed a terminal carboxylic acid moiety.  Therefore increasing 
the pH of the solution to pH 9, via titration with 1M NaOH, resulted in deprotonation of the 
terminal species and full dissolution.  Protonation of the terminal carboxylic acid via subsequent 
titration with 0.5M HCl to pH 6-7 resulted in the formation of a homogenous gel at concentrations 
above the minimum gelation concentration for the peptide.  pH was verified using Whatman pH 
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paper.  Gels were allowed to develop for 24 hours.  Self-assembly and the formation of a self-
supporting gel was verified through the use of an inversion assay as previously described.22  Gels 
and solutions were differentiated based on flow characteristics with solutions demonstrating flow 
properties and gels remaining suspended. 
 
Cryo-Scanning Electron Microscopy (Cryo-SEM) 
Samples were freshly prepared via pH induction as outlined and analyzed for 3D fibrous 
morphologies.  Cryo-SEM images were collected by high vacuum freeze-drying using a Hitachi 
Analytical Benchtop SEM TM3030 (Hitachi High-Technologies Europe, Berkshire, UK) with 
Deben Cool Stage (Deben, Suffolk, UK), using a method similar to that of Pogorelov and 
colleagues.23  Vacuum lyophilization was applied at 2 ºC and images obtained at -10 ºC, over a 
range of magnifications (15x – 30,000x) and 15 kV accelerating voltage. 
 
Transmission electron microscopy (TEM) 
TEM was performed using a FEI Morgagni 268 transmission electron microscope (FEI 
electronics, Burlington, Massachusetts, USA) and a negative staining technique.24  400 mesh 
copper grids were coated with continuous thick carbon film (~35 nm) having been previously glow 
discharged to increase their hydrophilicity.  4 μL samples were placed on the grid and rinsed three 
times with doubled distilled water.  The grid was stained three times by a 2% w/v solution of uranyl 
acetate.  Excess stain solution from the edge of the grid was removed using filter paper.  Grids 
were allowed to air dry before immediate examination.   
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Fourier Transform Infrared Spectroscopy (FTIR) 
Hydrogel samples (2-0.5% w/v) were prepared as described previously but with D2O replacing 
water.25 Prepared D2O containing hydrogels were sandwiched between two CaF2 25 mm2 discs 
(0.05 mm spacer).  FTIR spectra were obtained using a Jasco 4000 series FTIR spectrometer (Jasco 
Inc. Tokyo, Japan), between the wavelengths 4000-400 cm-1 with resolution 2 cm-1 and an average 
of 128 scans.  The spectrum of deuterated water was used as a background and subtracted from all 
spectra. 
 
Circular Dichroism (CD) 
CD was performed using a Jasco J815 Spectropolarimeter and quartz cuvette 1 mm path length, 
with 1 s integrations, 1 accumulation and a step size of 1 nm with a band width of 1 nm over a 
range of wavelengths from 180 to 300 nm at 25 ºC. Peptide samples were prepared 24 hours 
previously to allow for hydrogelation.  Measurements were repeated three times and mean value 
plotted.  Control samples (sterile distilled water, 1M NaOH, 0.5M HCl, pH 7.4) did not display 
any signal. 
 
Oscillatory Rheology 
The viscoelastic properties of the samples were determined using oscillatory rheology performed 
on a TA AR1500 rheometer at 25 °C.  A 20 mm steel parallel plate was employed with a set gap 
of 500 µm.  400 µL samples were applied to the plate using a pipetman.  An oscillatory stress 
sweep was performed to determine the linear viscoelastic region (LVR) of each sample.  This 
region, which is determined according to a superposition principle, is the area where stress is 
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directly proportional to strain.  There is a linear relationship between the two variables.  Following 
this, an appropriate stress within the LVR was selected and a frequency sweep was performed at a 
range of 1-10 Hz with the selected stress remaining constant for each sample.  Three distinct 
replicates for each sample were obtained and the storage modulus (G’) and loss modulus (G’’) 
determined. 
 
Biofilm Susceptibility Assay 
All microbial strains tested: Staphylococcus epidermidis (ATCC 35984); Staphylococcus aureus 
(ATCC 29213); Pseudomonas aeruginosa (PAO1) and Escherichia coli (NCTC 11303) were 
stored at -70 °C in Microbank vials (Pro-Lab Diagnostics, Cheshire, UK), and subcultured 
separately in Müller Hinton Broth (MHB) for 24 hours at 37 °C before testing.  Upon visual 
confirmation of growth the inoculum was taken and adjusted to optical density 0.3 at 550 nm in 
Quarter Strength Ringers Solution (QSRS), equivalent to 1 x 108 colony forming units per milliter 
(CFU/mL).  This suspension was further diluted in MHB (1 in 50) and dispensed aseptically in 
100 µL aliquots to each well of the microtitre plate, corresponding to 2 x 106 CFU/mL.  Biofilms 
were formed on the surface of the well under shear stress provided by a Gallenkamp gyrorotary 
incubator at 37 ºC.  After an inoculation period of 24 hours cultures were decanted and the plates 
irrigated thrice with 200 µL of sterile autoclaved 0.9% w/v sodium chloride (NaCl) in each well.  
Washed plates were tapped gently upside down on a sterile paper towel to remove residual wash.  
The prepared biofilm was treated for evaluation of viability using alamarBlue® in a method similar 
to that used by Pettit.26 100 µL of 2.0 1.5, 1.0 and 0.5% w/v NapFF, NapFFKK, NapFFFKK, 
NapFFOO and NapFFK’K’ were pipetted into separate wells of the microtitre plate and biofilms 
assessed for reduction in viability after 24 hours exposure.  Gels were removed from the microtitre 
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plates by three rinses of each well with NaCl.  A range (3-0.5% w/v) of HPMC gels (see 
supplementary data, Figure S21) were used as a standard non antimicrobial hydrogel comparator 
to ensure removal of gels did not remove significant quantity of biofilm bacteria.  HPMC has 
previously been shown to possess no significant antimicrobial activity.27  HPMC displayed no 
significant reduction of viable biofilm compared to positive controls (no gel),  thus ensuring the 
validity of the assay and methods employed.  The viability of established biofilms is assessed by 
re-charging wells with 100 µL of MHB containing 20% v/v alamarBlue®, incubating the plate at 
37 °C for two hours to allow development, followed by spectrophotometric measurement of 
absorbance at a wavelength of 570 nm (Tecan Sunrise® plate reader).  AlamarBlue® contains 
resazurin, a redox indicator which is reduced by the metabolic activity of viable microbial cells to 
develop into pink fluorescent resorfurin.  Positive control (100% microbicidal effect) corresponds 
to blank wells (no bacterial biofilm) treated with 70% ethanol (added, removed and allowed to 
dry) immediately prior to the addition of 20% v/v alamarBlue®.  Eight replicates were performed 
at each concentration.  Reduction in viability of biofilm following exposure to test formulation is 
expressed as a percentage based on percent reduction between untreated (blank) wells and treated 
wells using the following equation: 
 
100
70
Peptide
5700
0570
570570
0
0 x
BlankAbsEthanolAbs
BlankAbsAbsviabilityinreduction
nmnm
nmnm
−
−
≡
 
 
 
Cell Viability Assay 
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Murine fibroblast subcutaneous connective tissue cell line, NCTC Clone 929 (ATCC CCL 1), 
was cultured in Minimum Essential Medium (MEM) containing phenol red with Earle’s Salts and 
L-Glutamine, supplemented with 10% Horse Serum, 100 iu/mL penicillin and 100 µg/mL 
streptomycin supplied by Invitrogen (Paisley, UK).  Cells were grown at 37 ºC and 5% CO2 and 
subcultured at 80 – 90 % confluency.  Subculturing consisted of removal of spent medium, rinsing 
of the adherent cell surface with sterile autoclaved PBS before treatment with a 0.05% trypsin/0.53 
mM EDTA·4Na solution (Invitrogen, Paisley, UK) for cell monolayer detachment.  Cell viability 
was assessed by means of a quantitative alamarBlue® assay, similar to that utilized by O’Brien 
and colleagues.28  Cells were cultured (until at least third passage) and inoculated into 96-well 
tissue culture treated microtitre plates at a concentration of 1 x 104 cells/well and incubated at 37°C 
and 5% CO2 for 24 ± 1 hour, until approximately 90% confluency.  After this time, the medium 
was removed and replaced with 100 µL of 2.0 1.5, 1.0 and 0.5% w/v NapFF, NapFFKK, 
NapFFFKK, NapFFOO, NapFFK’K’ in separate wells of the microtitre plate and cell monolayers 
exposed for 24 hours.  Absorption was measured at 570 nm in a Tecan Sunrise® plate reader after 
a development time of 10 hours.  A positive control (100% reduction in viability) was also included 
in the assay using 70% ethanol.  The negative control (untreated) consisted of tissue culture cells 
in 100 µL phosphate buffer saline (PBS).  Percentage cell viability was calculated relative to 
untreated control wells as per the biofilm assay above.  This value was subtracted from 100 to 
provide a percentage viability value displayed in Figure 6.  3-0.5% w/v HPMC controls (Figure 
S22) displayed no significant reduction of viable fibroblast cells compared to positive controls (no 
gels), thus confirming the validity of the study. 
 
Hemolysis  
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All peptide gels/solutions were assayed spectrophotometrically for their ability to induce 
hemoglobin release from fresh equine erythrocytes according to the method previously 
described.21  Fresh defibrinated equine erythrocytes were washed three times with equal volumes 
of PBS.  After centrifugation for 15 minutes at 900 g erythrocytes were resuspended to 4% v/v in 
PBS.  Equal volumes (100 µL) of the erythrocyte suspension were added to each well of a 96-well 
microtitre plate.  Erythrocytes were subsequently exposed to peptide concentrations of 2.0-0.5% 
w/v, incubated at 37 °C for 1 hour and centrifuged at 1000 g.  Aliquots of the supernatant were 
transferred to a fresh 96-well microtitre plate, and hemoglobin release measured 
spectrophotometrically at 405 nm (Tecan Sunrise® plate reader).  As a positive control (100% 
hemolysis), erythrocytes were treated with 0.1% Triton X-100, whilst PBS (0% hemolysis) acted 
as a negative control.  All peptide concentrations are reported as the mean of six replicates.  
Percentage hemolysis was calculated as follows:  
 
100
%1.0
Peptide
405405
405405
0
0 x
PBSAbsTritonXAbs
PBSAbsAbsHemolysis
nmnm
nmnm
−
−
≡
 
 
Statistical Analysis 
Statistical analyses were performed using GraphPad Prism 6.  Standard deviations were obtained 
at each concentration of peptide tested based on eight replicates for quantitative biofilm viability 
assays and mean values obtained.  For cell cytotoxicity assays standard deviations and mean values 
were also obtained from eight replicates at each concentration.  Statistical analyses were employed 
using a Kruskal-Wallis test, with a Dunn’s multiple comparisons test used to identify individual 
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differences between the reduction in biofilm viability for each peptide hydrogel and the positive 
control (0% reduction).  A Kruskal-Wallis test, followed by a Dunn’s multiple comparisons test, 
was also utilized for statistical analysis of tissue culture cytotoxicity data by comparison of 
percentage viability for the peptides employed to the positive control (100% viability), with 
significant reduction in viability reported.  Hemolysis data was compared by the same statistical 
method with percentage hemolysis compared to the PBS, non-hemolytic, control (0% hemolysis). 
Non parametric Kruskal-Wallis tests were employed rather than parametric Analysis of Variance 
(ANOVA) as data was shown to be non-normally distributed using the Kolmogorov and Smirnov 
method.  In all cases a probability of P<0.05 denoted significance. 
 
Results and Discussion 
Gel Inversion Assay 
The ability of the naphthalene peptide derivatives to self-assemble and therefore gel at 
physiological pH is determined largely by the intermolecular forces of attraction between the 
primary structure and the solvent molecules, predominantly water in this case.  NapFF has been 
previously characterized to form a self-supporting gel at concentrations as low as 0.4% w/v in 
water, due to extensive π-π interactions between aromatic groups present on the naphthalene and 
phenylalanine residues.29 
The presence of two lysine or ornithine residues in the primary sequence confers increased 
hydrophilic, cationic charge to the molecule thereby increasing the minimum gelation 
concentration, to 1.0% w/v, relative to NapFF (Table 1).  The inclusion of three phenylalanine 
residues increased the overall hydrophobic character of the NapFFFKK molecule compared with 
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NapFFKK, however not sufficiently to enable gelation to occur at 0.5% w/v (refer to 
supplementary information for full set of optical images: Figures S6-S8).  The inclusion of an extra 
phenylalanine group did not appear to have as a significant effect on driving hydrogelation when 
conjugated to two lysine or ornithine groups.  For NapFFK’K’, lysine molecules formed peptide 
bonds to neighboring amino acids via their respective side chain amino (R)  group.  They are linked 
molecularly by the epsilon (ε) amino group rather than the standard amino grouping, thus allowing 
gelation to occur at 0.5% w/v peptide.  The inclusion of the R-group amine into an isopeptide bond 
with the carboxylic acid of phenylalanine may lessen the availability of the free primary amine (-
NH2) on lysine to partake in hydrogen bonding with water, as the carbon tail has been reduced 
from a butyl amine (-CH2-CH2-CH2-CH2-NH2)  to direct covalent attachment to the α-carbon.  
  
Table 1. Minimum gelation concentration (% w/v) of naphthalene-based peptides   
Peptide Minimum gelation concentration of 
synthesized peptides (% w/v) 
NapFF 0.5 
NapFFKK 1.0 
NapFFK’K’ 0.5 
NapFFOO 1.0 
NapFFFKK 1.0 
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Figure 2.  Optical images of gel (A) NapFFOO, (B) NapFFKK, (C) NapFFK’K’, at a concentration 
of 1% w/v and pH of 7.4 in water 
 
Cryo-SEM, TEM, FTIR and CD Spectroscopy 
The supramolecular hydrogels display random high entanglements of densely packed three 
dimensional fiber structures as confirmed by cryo-SEM and TEM.  Micrographs show that all 
hydrogels, for the five peptide variants, possess a similar fibrous nature (Figures S9-S12).  TEM 
images for NapFFOO, NapFFKK and NapFFK’K’ (Figure 3) confirm the densely packed nature 
of these structures and their nanoscale architecture (NapFF TEM images, Figure S13).  FTIR 
spectra (Figure S14) display strong transmittance troughs in the amide I region at approximately 
1627 cm-1 and shoulders at ~1570 cm-1.  These are indicative of possible β-sheet secondary 
structures in the presence of supramolecular hydrogels at 2% w/v peptide.30,31  However, the 
transmittance bands are less pronounced than for other larger peptides studied.32,33  There is 
acknowledgement with the field that contradictory models for molecular structure exist for short 
self-assembled peptides.16  FTIR spectra for polypeptide sequences and proteins, which possess 
the antiparallel form of β-sheet conformation, show a characteristic large and sharp trough between 
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1615 and 1638 cm-1, attributed to β-sheet formation.  A generally weaker peak at around 1672-
1694 cm-1 signifies an antiparallel confirmation.  The peptide spectra recorded display quite a 
different spectral fingerprint, with possible merging of troughs in this area.  The wide band stretch 
to 1650 cm-1 may be misinterpreted as the presence of α-helical conformations.34  Although it has 
been well established that the short peptide length, less than 7 amino acids, prevents this 
conformation.35,36  The primary structures of the peptides studied fit with the requirements of a β-
sheet secondary structure, namely; surfaces that are highly polar via side chain groups (lysine, 
ornithine) and capable of hydrogen bonding, correlating with surfaces that contain nonpolar, 
hydrophobic side chains (phenylalanine, naphthalene).37  
The supramolecular arrangement and secondary structure of the peptide hydrogels were 
confirmed by CD spectroscopy (Figures S15 and S16).  The CD spectra display a negative peak at 
218 nm (n-π* transition) and a positive peak at 197 nm (excitation splitting of lowest peptide π-
π*) at concentrations above the minimum gelation concentration for all peptides.  These signals 
(below 240 nm: far UV) are similar to the CD signals for β-sheet polypeptides and confirm the 
self-assembled peptide backbone predominantly forms a β-sheet arrangement.  0.5% w/v 
NapFFKK, NapFFOO and NapFFFKK do not display a corresponding β-sheet CD spectrum due 
to an absence of higher ordered structures below the minimum gelation concentration.  A less 
ordered random-coil spectrum is observed for each, with negative and positive bands at ~200 nm 
and ~220 nm respectively.  Broad positive peaks at ~240 nm are indicative of π-π* transitions of 
aromatic phenyl groups.  Smaller positive bands at 286 nm and 296 nm correspond to π-π* and n-
π* transitions the naphthalene aromatic group.38  The CD spectra are similar to the antiparallel β-
sheet orientation proposed by Adams and co-workers, with π-π interactions between adjacent 
naphthalene groups form an extended two-dimensional sheet structure.39 Signals indicating β-sheet 
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configuration (transitions at 197 nm to 218 nm) increase in magnitude relative to increased 
concentration and gel strength (at 2% w/v: NapFFK’K’ > NapFFOO > NapFFKK > NapFFFKK 
for the cationic naphthalene variants.  This corresponds with the observed storage moduli trends 
(Oscillatory rheology).  
 
 
Figure 3. Transmission electron microscopy (TEM) images of (A) NapFFOO, (B) NapFFKK, (C) 
NapFFK’K’, at a concentration of 1% w/v  and pH of 7.4 in water. 
 
Oscillatory Rheology 
Frequency sweep analysis (Figures S17b and S18b) confirmed that at 2% and 1% w/v 
naphthalene hydrogels are primarily elastic in nature.  For all peptides, the storage modulus (G’) 
was proven to be greater than the loss modulus (G’’) across a range of frequencies tested within 
the relevant LVR obtained by oscillatory stress sweeps (Figures S17a and S18a).  The naphthalene 
hydrogels display the mechanical properties of a typical rigid, self-supporting hydrogel with G’ 
values larger than G’’ by at least an order of magnitude.30  Within the LVR the storage and loss 
moduli of 2% and 1% w/v hydrogels are relatively constant in the range of frequencies studied.  
This confirms the presence of a non-covalent cross-linked network of fibers formed by a 
combination of hydrogen bonding, π-π stacking and van der Waals’ interactions.40,41  Comparison 
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of the storage moduli for each of the naphthalene peptides demonstrated a large range of gel 
rigidities.  All peptides display a concentration dependent increase in the mean storage modulus 
(G’) as the peptide concentration rises from 1% to 2% w/v.  There is also correlation between 
minimum gelation concentration and G’ between peptides.  The relative magnitudes of G’ at 2% 
w/v are ranked as follows: NapFFK’K’ (5830 Pa) > NapFFOO (1346 Pa) > NapFFKK (195 Pa) > 
NapFFFKK (180 Pa) for the cationic naphthalene variants.  NapFFK’K’ produced the most rigid 
hydrogel.  An increase in rigidity for NapFFK’K’ gels may be due to decreased availability of the 
primary amine to form hydrogen bonds with water compared with standard NapFFKK.  Variation 
in the molecular structure resulted in an increase in G’ and a decrease in G’’ for NapFFK’K’, 
relative to NapFFKK and NapFFOO.  This may be attributed to a reduction in the ability of 
NapFFK’K’ to dissolve fully in water to form a solution.  Single atom substitutions have been 
shown previously to significantly affect side chain π-π interactions on ortho, meta and para 
positions of phenylated side chains.42  It is possible that elongation of the amine conjugated side 
chain (R-group) in lysine may similarly inhibit the complementary π-π stacking interactions 
between neighboring phenyl side chains as the steric bulk of the NapFFKK molecule increases.  
This was also demonstrated for NapFFFKK as a similar G’ (180 Pa) to NapFFKK was observed 
at 2% w/v.  Direct covalent attachment of the free amine to the α-carbon in the epsilon variant is 
sterically favorable to drive self-assembly.  This was observed by the formation of NapFFK’K’ 
gels at lower concentrations (0.5% w/v) relative to NapFFKK, NapFFOO and NapFFFKK, with 
more rigid gels obtained at the same concentrations.  Tuning rheological properties to the necessary 
requirements remains one of the greatest challenges in the production of short self-assembling 
peptide variants.  Assembly kinetics and the gelation process are as significant to the overall 
mechanical properties as molecular structure.43,44  
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Biofilm Susceptibility Assay 
The ability of the peptide self-assembled hydrogels to reduce viable biofilm was demonstrated 
against four key species of bacteria associated with biomaterial related infection: Gram-positive 
Staphylococcus epidermidis (ATCC 35984) and Staphylococcus aureus (ATCC 29213), and the 
Gram-negative pathogens Pseudomonas aeruginosa (PAO1) and Escherichia coli (NCTC 11303) 
(Figures 4, S19, S20 and 5 respectively).45,46  Ultrashort naphthalene self-assembled gels 
containing two lysine residues (NapFFKK and NapFFFKK) displayed the most significant 
(P<0.001) antibiofilm activity at the concentrations tested.  NapFFKK and NapFFFKK displayed 
significant reduction (P<0.05) of biofilm, 87.5% and 81.25% respectively, across all four 
concentrations employed and all four pathogens tested (16 variables in total).  2% w/v NapFFKK 
hydrogels were shown to reduce viable biofilm by 94% against Staphylococcus epidermidis, with 
2% w/v NapFFFKK demonstrating 85% reduction.  The addition of an extra phenylalanine does 
not adversely affect either gelation (minimum gelation retained at 1% w/v: no visible precipitation 
occurred) or antibiofilm activity.  By comparison NapFFK’K’ gels showed no significant 
antibiofilm activity at any of the variables (4 concentrations and 4 pathogens) analyzed.  The major 
difference in the structure of NapFFKK and NapFFK’K’ is the length of the methyl chain on the 
lysine R-group.  We hypothesize that modification of the methylene chain, from a butyl amine to 
direct covalent attachment on the α-carbon, has reduced the antibiofilm activity of the NapFFK’K’ 
peptide.  This theory is further supported by the data obtained for NapFFOO.  Ornithine has one 
less methylene unit (forming a propyl amine) on its R-group than lysine.  This subtle molecular 
difference has little effect on the gelation ability of the two respective peptides (Table 1: both 1.0% 
w/v) but it does have a significant effect on antibiofilm activity.  The primary amine of the R-
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group tail is not as readily available to interact with the negatively charged bacterial membrane 
and its constituent acidic molecules including: acidic hydroxylated phospholipids such as 
cardiolipin, phosphatidylglycerol and phosphatidylserine; lipopolysaccharides; and teichoic acid.  
This is a key parameter of antimicrobial peptide activity.19   
It has been previously established that a minimum of two charged and two hydrophobic amino 
acid units are required to confer antimicrobial activity to ultrashort peptide variants, providing 
validation to the primary structures we have selected.47  NapFF displays significant reduction in 
viable biofilm at concentrations of 1.5% w/v and above against Staphylococcus epidermidis, 
Escherichia coli and Pseudomonas aeruginosa.   This is likely due to hydrophobic interactions 
and detergent-like effects with bacterial membranes at higher concentrations.  The addition of 
charged moieties increases the antibiofilm activity of the NapFF molecule, with the exception of 
NapFFK’K’.  The addition of K’K’ may have resulted in a sub-optimal hydrophobic: charge 
balance in the molecule, thereby decreasing interaction with bacterial membranes and reducing 
antimicrobial activity.   
NapFFFKK is the only peptide hydrogel to display significant activity against Staphylococcus 
epidermidis (ATCC 35984) at both 1 and 0.5% w/v.  This phenomenon can be explained by an 
increase in the hydrophobicity of NapFFFKK relative to NapFFKK.  The inclusion of a single 
phenylalanine has allowed an optimum hydrophobic: charge balance to be obtained.19  Therefore 
NapFFFKK is able to penetrate and eradicate Staphylococcus epidermidis (ATCC 35984) biofilm 
at lower concentrations.  NapFF does not have sufficient cationic charge or hydrophobicity at the 
lower concentrations to induce biofilm eradication.  Greater biofilm eradication occurs in Gram-
positive Staphylococcus aureus (ATCC 29213) relative to Staphylococcus epidermidis (ATCC 
35984) for all peptides due to differences in the biofilm architecture of the two isolates of Gram-
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positive bacteria employed.  Staphylococcus epidermidis (ATCC 35984) forms a notoriously thick 
biofilm matrix that retards the penetration of a multitude of antibiotics.  Staphylococcus aureus 
(ATCC 29213) also forms a thick biofilm but it is relatively fragile by comparison; as confirmed 
by Di Stefano.48  Lysine is able to penetrate the thick biofilm matrix of Staphylococcus epidermidis 
(ATCC 35984), to a greater extent than ornithine based peptides by attacking its membrane 
architecture.  This is due to the increased availability of the free primary amine.  NapFFKK does 
not have sufficient hydrophobic character to cause significant reduction of Staphylococcus 
epidermidis biofilm at lower concentrations (≤ 1% w/v).   
A trend of increasing antibiofilm activity is apparent relative to increasing concentration for 
NapFF, NapFFKK, NapFFOO and NapFFFKK irrespective of whether self-assembly has 
occurred.  Therefore if antimicrobial activity cannot be conclusively linked to the process of self-
assembly, the possibility exists that antimicrobial activity may be due in part to the presence of 
soluble cationic peptide in the area surrounding the hydrogel surface.  
 Research by Salick and colleagues similarly debated this issue.49  They showed the higher 
molecular weight, 20 residue, MAX1 hydrogel to display an inherently antimicrobial surface.  
Similar to our ultrashort derivatives gelation occurred at greater than 0.5% w/v, indicating that the 
soluble aggregates are likely to be the most active species as bacterial proliferation in the presence 
of lower levels of soluble MAX1 was comparable to bacterial samples with no peptide.  The 
surface structure of MAX1 is similar to NapFFKK, NapFFOO and NapFFFKK, with a 
polycationic lysine-rich face that may be responsible for broad-spectrum antibacterial activity.  
The Schneider group utilized this knowledge and the MAX1 template to produce second 
generation cationic self-assembly hydrogels possessing both arginine and lysine.  MARG1, 
containing two arginine residues, was highly active against methicillin resistant Staphylococcus 
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aureus, whilst PEP6R, containing six arginines, demonstrated a broad spectrum of activity against 
Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa.50,51    
Similarly our self-assembled hydrogels are composed of a hydrophobic naphthalene and 
phenylalanine core with cationic ornithine and lysine exteriors, at a reduced peptide length and 
cost.  In the fibrous hydrogel form the cationic amino acids are available to displace divalent metal 
ions from the bacterial cell well causing membrane disruption in biofilm cells and leading to cell 
death in both Gram-positive and -negative pathogens.52  The successful reduction achieved by our 
ultrashort cationic peptide hydrogels in the more resistant biofilm phenotype of bacteria is 
important for translating these molecules into biomaterial and biomedical therapies as these are 
the primary causative phenotype in medical device related infection.53  
The diphenylalanine motif has demonstrated previous success as an antimicrobial self-
assembled carrier molecule.  Paladini and colleagues created a silver-doped self-assembling 9-
fluorenyl-methoxycarbonyl (Fmoc) derivative (Fmoc-FF) wound dressing.  This demonstrated 
99% inhibition of the planktonic Staphylococcus aureus phenotype when 2% silver nanoparticles 
were incorporated into the hydrogel matrix and coated onto flax.54  Debnath et al, utilized Fmoc-
based amphiphiles with cationic moieties allowing for broad spectrum antibacterial activity against 
less resistant planktonic forms of Gram-positive and -negative bacteria, including Staphylococcus 
aureus, Escherichia coli and Pseudomonas aeruginosa.33  Self-assembled peptides have high 
potential for wound dressings, biomaterials and other biomedical applications due to their fibrous 
architecture and high water content, mimicking the extracellular matrix and promoting healing.55  
Our ultrashort cationic naphthalene derivatives have the extra advantage of inherent antimicrobial 
activity for the prevention of infection.   
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Figure 4.  Percentage reduction of mature 24 hour Staphylococcus epidermidis (ATCC 35984) 
biofilm after 24 hour incubation with naphthalene derived self-assembled hydrogels utilizing an 
alamarBlue®  assay.  Results are displayed as a mean of 8 replicates.  Key: 
 
NS: no significant difference (P≥0.05), *: P<0.05, **: P<0.01, ***: P<0.001, ****: P<0.0001 
significant difference between Log10CFU/mL of peptide and the positive control (no peptide). 
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Figure 5.  Percentage reduction of mature 24 hour Escherichia coli (NCTC 11303) biofilm after 
24 hour incubation with naphthalene derived self-assembled hydrogels utilizing an alamarBlue®  
assay.  Results are displayed as a mean of 8 replicates.  Key: 
 
NS: no significant difference (P≥0.05), *: P<0.05, **: P<0.01, ***: P<0.001, ****: P<0.0001 
significant difference between Log10CFU/mL of peptide and the positive control (no peptide). 
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Cell Viability and Hemolysis  
The cytotoxicity of cationic naphthalene based peptides was evaluated against the International 
Standard cytotoxicity cell line CCL 1.  The results obtained (Figure 6) show reduced cell toxicity 
in comparison to bacterial biofilm cells.  Comparison of the results for all five peptides at the four 
concentrations employed against the CCL 1 cell line show significant (P<0.05) reduction in cell 
viability in under half of the samples tested (9 out of 20: 45%).  The most successful antibiofilm 
molecule, NapFFKK, is particularly cytotoxic displaying a significant reduction in viability at all 
concentrations tested.  NapFFK’K’ possesses the greatest cytocompatibility, with no significant 
toxicity demonstrated against murine fibroblasts, similar to activity against bacterial isolates.  
NapFF was previously found to show greater than 90% viability at 200 µM against HeLa cells.13  
Naphthalene was purposely chosen as a phenyl substituent due to its established safety profile.  It 
is utilized in many current pharmaceutical formulations including propranolol, naphazoline and 
nafronyl.56  
A relative reduction in activity against mammalian cells may be attributed to a neutral 
zwitterionic eukaryotic cell membrane due to the high proportion of phospatidylcholine, 
phosphatidylethanolamine, sphingomyelin, sterols, cholesterol and ergosterol.57  Therefore 
cationic peptides possess reduced selectivity for mammalian membranes, compared with 
negatively charged bacterial forms, as demonstrated previously by our group.21   
Further insight into the selectivity of our peptides for mammalian membranes was obtained via 
a hemolysis assay with results displayed in Figure 7.  Only NapFF and NapFFFKK displayed 
significant (P<0.05) hemolytic activity at the highest (2% w/v) concentrations employed.  This 
may be due to predominantly hydrophobic interaction with neutral erythrocyte cell membranes.  
All samples tested had a value of 15% hemolysis or less indicating the eukaryotic cell surface is 
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intact and that the majority of peptides are non-hemolytic.  No conclusive correlation was found 
between the degree of hemolysis and peptide gelation.   
The creation of stimuli-responsive molecules may further improve the selectivity of these 
peptides for bacterial pathogens.  For example, the Ulijn group synthesized a variety of Fmoc 
dipeptide amphiphiles that demonstrated enzyme responsive antibacterial activity and gelation in 
the presence of alkaline phosphate producing Escherichia coli.58  Bacterial proteases, such as 
sortase, could provide valid targets for specific infections, in this case staphylocococci.59  Other 
environmental stimuli that could be harnessed include modification of the pH switch used to 
control the process of self-assembly in our hydrogels.  Urinary catheter infections associated with 
Proteus mirabilis display an increased pH clinically.  Therefore reversing assembly to occur at 
high pH, via alteration of the primary amino acid sequence, may prove beneficial in such 
infections.60  
The antimicrobial motifs have the potential to be conjugated directly to the surface of medical 
devices.  Peptides have the flexibility to be conjugated to biomaterials with precision.  Methods 
for attachment include grafting via peptide reactive polymers such as polyethylene glycol and N-
(2-hydroxypropyl)methacrylamide.61  Successful translation of self-assembled peptides into 
therapeutics is provided by the example of Lanreotide growth inhibitor.62  Self-assembly of this 
octapeptide occurs via hydrophobic and aromatic interaction, a mechanism similar to our 
naphthalene variants.  As a somatostatin analogue, it is indicated for growth hormone-secreting 
tumors, displaying prolonged action and an increased half-life.63  Lanreotide provides significant 
promise to the development and future use of self-assembling peptides as pharmaceuticals. 
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Figure 6.  Percentage viability of CCL 1 [NCTC clone 929]- murine fibroblasts subcutaneous 
connective tissue monolayer cells after 24 hour exposure to naphthalene derived self-assembled 
hydrogels utilizing an alamarBlue®  assay.  Results are displayed as a mean of 8 replicates.  Key: 
 
NS: no significant difference (P≥0.05), *: P<0.05, **: P<0.01, ***: P<0.001, ****: P<0.0001 
significant difference between Log10CFU/mL of peptide and the positive control (no peptide). 
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Figure 7.  Percentage hemolysis of the naphthalene peptides against equine erythrocytes.  Each 
value is expressed as the mean of six replicates, incubated at 37 °C for 1 hour.  Key: 
 
NS: no significant difference (P≥0.05), *: P<0.05, **: P<0.01, ***: P<0.001, ****: P<0.0001 
significant difference between Log10CFU/mL of peptide and the positive control (no peptide). 
 
Conclusions 
In this study we explored the in vitro antibacterial properties of ultrashort cationic naphthalene 
peptides against the more resistant biofilm bacterial phenotype associated with implant related 
infections.  The peptide backbone allows for tunable structural and chemical characteristics based 
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on amino acid selection.  The use of ultrashort variants has high potential for biomedical 
development compared with larger peptides and proteins due to reduced cost of production and 
ease of synthesis, without a reduction in function. We found that the composition of the amino 
acid R-group significantly influenced antibiofilm properties but not gelation propensity for these 
peptides. The nanofiber structure of these supramoleular hydrogels were confirmed using cryo-
SEM and TEM microscopy.  Antibiofilm activity tended to increase with increasing peptide 
concentration.  Greater selectivity was shown against biofilm bacteria compared with mammalian 
cells for these cationic peptides. The lysine containing ultrashort cationic naphthalene peptides 
show particular promise in eradicating biofilm forms of medical device related pathogens.  Further 
research is required to permit gelation and antimicrobial activity in response to the development 
of bacterial environmental stimuli in vivo, utilizing factors such as pH, enzymatic and molecular 
recognition.  Thus ensuring antimicrobial activity occurs when it is most required and limiting side 
effects to patients.  The research presented in this paper has fundamental implications for the 
design and development of innovative biomaterials, tissue scaffolds and drug delivery systems 
based on the ultrashort cationic naphthalene peptide motif.  
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